T1	Participants 125 160	squamous cell head and neck cancer.
T2	Participants 317 361	squamous cell carcinoma of the head and neck
T3	Participants 363 548	One hundred and fifty-three patients (all of whom had stage III or IV unresectable disease with no distant metastases and who had received two cycles of taxol and cisplatin chemotherapy
T4	Participants 1713 1764	patients with locally advanced head and neck cancer
